Tom Freeman is Senior Director, Translational Systems Immunology, at Johnson & Johnson Innovative Medicine.

Prior to joining Johnson & Johnson Innovative Medicine in June 2020, Tom Freeman had a long academic career working in different areas of innate functional genomics, immunity and computational biology. He held the chair of Systems Immunology at the University of Edinburgh and before this led Gene Expression Group at the Sanger Institute (1994-2000) before joining the MRC HGMP-Resource Centre (2000-2005), also on the Hinxton Campus, where he headed up the UK National Microarray Programme.

His interest in data analysis and generating expression atlases led to him to develop a number of well-known network analysis tools and approaches. He has founded two companies in the data analytics space and authored over 160 peer-reviewed articles. Tom is now a Senior Director at Johnson & Johnson Innovative Medicine, where he heads the Translational Systems Immunology Group, which is focused on delivering portfolio-facing computation analyses in support of patient stratification, biomarker identification, analysis of clinical trials data and delivering precision medicine.

Lunch will be served at 12.30 prior to the seminar.